Expression of alpha-synuclein in non-apoptotic, slowly degenerating facial motoneurones

Journal of Neurocytology

Volumn 30, Issue 6, 2001, Pages 515-521

  Moran, L B ^a   Kosel S ^a   Spitzer, C ^b   Schwaiger, F W ^c   Riess, O ^d   Kreutzberg, G W ^e   Graeber, M B ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c Aurigon Life Science GmbH   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL NUCLEUS; CONFOCAL MICROSCOPY; CYTOTOXICITY; DEGENERATIVE DISEASE; DISEASE SEVERITY; FACIAL NERVE; GLIA; IMMUNOREACTIVITY; LEWY BODY; MISSENSE MUTATION; MOTONEURON; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE CRUSH; NERVE FIBER TRANSECTION; NERVE TRANSECTION; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; RAT;

ALPHA-SYNUCLEIN; ANIMALS; APOPTOSIS; AXOTOMY; FACIAL NERVE; MOTOR NEURONS; NERVE CRUSH; NERVE DEGENERATION; NERVE TISSUE PROTEINS; RATS; RATS, INBRED LEW; SYNUCLEINS;

ANIMALIA;

EID: 0035742561     PISSN: 03004864     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015697318437     Document Type: Article

References (51)

1. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
2. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
3. Displacement of synaptic terminals from regenerating motoneurons by microglial cells
4. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease
5. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
6. Study on facial motoneuronal death after proximal or distal facial nerve transection
7. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis
8. From neuronal inclusions to neurodegeneration: Neuropathological investigation of a transgenic mouse model of Huntington's disease
9. Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments
10. Peripheral nerve regeneration
11. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
12. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro
13. Filamentous nerve cell inclusions in neurodegenerative diseases: Tauopathies and alpha-synucleinopathies
14. Nigral neurons are likely to die of a mechanism other than classical apoptosis in Parkinson's disease
15. Astrocytes increase in glial fibrillary acidic protein during retrograde changes of facial motor neurons
16. Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease
17. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development
18. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
19. Alpha-synuclein. Axonal transport, ligand interaction and neurodegeneration
20. Axonal transport of synucleins is mediated by all rate components
21. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation
22. Cell death of axotomized motoneurones in neonatal rats, and its prevention by peripheral reinnervation
23. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
24. Characterization of spinal motoneuron degeneration following different types of peripheral nerve injury in neonatal and adult mice
25. The axon reaction: A review of the principal features of perikaryal responses to axon injury
26. Apoptosis, oncosis, and necrosis. An overview of cell death
27. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
28. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation
29. Alpha-synuclein shares physical and functional homology with 14-3-3 proteins
30. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
31. Abortive apoptosis in Alzheimer's disease
32. Caspases, apoptosis, and Alzheimer disease: Causation, correlation, and confusion
33. Induction of neuronal death by alpha-synuclein
34. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
35. The effect of peripheral nerve injury on immature motor and sensory neurons and on muscle fibres. Possible relation to the histogenesis of Werdnig-Hoffmann disease
36. GAP-43 (B-50) and C-Jun are up-regulated in axotomized neurons of Clarke's Nucleus after spinal cord injury in the adult rat
37. Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT)
38. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation
39. An alternative, nonapoptotic form of programmed cell death
40. alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
41. Alpha-synuclein in Lewy bodies
42. Quantitative ultrastructural observations on the inhibited recovery of the hypoglossal nucleus from the axotomy response when regeneration of the hypoglossal nerve is prevented
43. Reaction of motoneurons and their microenvironment to axotomy
44. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
45. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
46. Alpha-synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro
47. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease
48. Neuropathology in mice expressing human alpha-synuclein
49. Cellular responses to axotomy and related procedures
50. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded
51. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells